More specifically it was observed that by inhibiting the transcriptional activity of the JAK/STAT pathway in CTCL patients, one could re-sensitize resistant CTCL cells to vorinostat induced apoptosis [99]. The gene discussed is SOAT1; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.